Logo image
Differential BMP Signaling Mediates the Interplay Between Genetics and Leaflet Numbers in Aortic Valve Calcification
Journal article   Open access   Peer reviewed

Differential BMP Signaling Mediates the Interplay Between Genetics and Leaflet Numbers in Aortic Valve Calcification

Jae-Joon Jung, Azmi A. Ahmad, Saranya Rajendran, Linyan Wei, Jiasheng Zhang, Jakub Toczek, Lei Nie, Gunjan Kukreja, Mani Salarian, Kiran Gona, …
JACC. Basic to translational science, Vol.7(4), pp.333-345
04/2022
DOI: 10.1016/j.jacbts.2021.12.006
PMCID: PMC9079798
PMID: 35540096
url
https://doi.org/10.1016/j.jacbts.2021.12.006View
Published (Version of record) Open Access

Abstract

[Display omitted] •The neuropilin-like protein, DCBLD2, is down-regulated in aortic valves of patients undergoing valve replacement for aortic stenosis.•About 50% of DCBLD2-deficient mice develop bicuspid aortic valve. These animals have a high prevalence of calcific aortic valve disease with typical features of human disease, including aortic stenosis.•DCBLD2 down-regulation up-regulates bone morphogenic protein 2, a key mediator of calcification. Despite a similar level of bone morphogenic protein 2 between bicuspid and tricuspid aortic valves, downstream signaling and expression of the calcification marker, osteocalcin are more pronounced in bicuspid aortic valves.•Introducing a clinically relevant model of calcific aortic valve disease, these findings may explain how a combination of genetic background and bicuspid aortic valve promotes aortic valve calcification and stenosis. Expression of a neuropilin-like protein, DCBLD2, is reduced in human calcific aortic valve disease (CAVD). DCBLD2-deficient mice develop bicuspid aortic valve (BAV) and CAVD, which is more severe in BAV mice compared with tricuspid littermates. In vivo and in vitro studies link this observation to up-regulated bone morphogenic protein (BMP)2 expression in the presence of DCBLD2 down-regulation, and enhanced BMP2 signaling in BAV, indicating that a combination of genetics and BAV promotes aortic valve calcification and stenosis. This pathway may be a therapeutic target to prevent CAVD progression in BAV.
aortic stenosis aortic valve bicuspid aortic valve calcification mouse models

Details

Metrics

Logo image